Adam Ang
It is the global multilingual version of the Japanese device NouKNOW.
SugoSure targets patients with type 2 diabetes below 65 years old.
Its HIPAA-compliant app has been used by around 800 health organisations in the United Kingdom, Australia, and New Zealand.
The consumer app enables users to monitor their own heart rhythm round the clock.
MConnekt assists healthcare practitioners to find clients and optimise workflow.
They plan to infuse AI, big data, and cloud technologies with digital therapeutics.
It also seeks to expand its base in India and boost product development.
The obstetrics and paediatrics app will be launched next year.
The research targets people with complex regional pain syndrome, post-stroke pain, and other pain-induced conditions.
The training programme was first developed in 2017 by an Australian cardiologist together with Janssen Pharmaceuticals.